Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Bronchogenic × Bronchoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 16 Carcinoma, Non-Small-Cell Lung 3 Pneumonia 2 Tuberculosis 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pulmonary Nodule Cm 1 Pulmonary Fibrosis 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Neoplasms 1 Lung Diseases, Interstitial 1 Hemoptysis 1 Carcinoma, Squamous Cell 1 Carcinoma, Bronchogenic 1 Bronchitis 1 Bronchiectasis 1

Interventions

Carboplatin 5 Paclitaxel 3 atezolizumab 2 Radiosurgery 2 Pemetrexed 2 Cisplatin 2 pembrolizumab 1 durvalumab 1 cemiplimab 1 Tyrosine Kinase Inhibitors 1 Radiotherapy 1 Platinum Compounds 1 Nivolumab 1 Mediastinoscopy 1 Magnetic Resonance Spectroscopy 1 Interleukin-15 1 Gemcitabine 1 Fluticasone 1 Exercise Therapy 1 Etoposide 1 Docetaxel 1 Dasatinib 1 Bronchoscopy 1 Blood Specimen Collection 1 Bevacizumab 1 Afatinib 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡